Literature DB >> 390784

Use of antithymocyte globulin for reversal of acute allograft rejection.

C F Shield, A B Cosimi, N Tolkoff-Rubin, R H Rubin, J Herrin, P S Russell.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 390784

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

Review 1.  The role of OKT3 in clinical transplantation.

Authors:  D J Norman; M R Leone
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 2.  Monitoring antithymocyte globulin in renal transplantation.

Authors:  K Clark
Journal:  Ann R Coll Surg Engl       Date:  1996-11       Impact factor: 1.891

Review 3.  Immunosuppression in older renal transplant patients.

Authors:  J M Morales; J M Campistol; A Andrés; J C Herrero
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

4.  Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

Authors:  T W Chang; P C Kung; S P Gingras; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

Review 5.  Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.

Authors:  A Osama Gaber; Anthony P Monaco; James A Russell; Yvon Lebranchu; Mohamad Mohty
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

Review 6.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

7.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847

8.  Murine anti-lymphocyte monoclonal antibodies fail to act as opsonins for allogeneic human peripheral blood polymorphonuclear phagocytes.

Authors:  D M Roberton; G M Georgiou; W M Ellis; C S Hosking
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.